A Pediatric Phase 1 Study Of Loxo-101, A Highly Selective Inhibitor Of The Tropomyosin Receptor Kinase (Trk) Family.Ramamoorthy Nagasubramanian,Steven G. DuBois,Theodore W. Laetsch,Leo Mascarenhas,Steven J. Smith,Mark Reynolds,Scott Cruickshank, Lia Donahue,Alberto S. Pappo,Michael C. CoxJOURNAL OF CLINICAL ONCOLOGY(2016)引用 2|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要